James Andrea S. 4
4 · Oncocyte Corp · Filed Feb 11, 2025
Insider Transaction Report
Form 4
James Andrea S.
Chief Financial Officer
Transactions
- Purchase
Common Stock, no par value
2025-02-07$2.05/sh+97,561$200,000→ 151,231 total
Footnotes (1)
- [F1]Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of February 7, 2025, by and among the Issuer and the investors signatory thereto.